BIIB

Trade Biogen Inc. - BIIB stock price

1m
5m
15m
30m
1H
4H
1D
1W
History

BIIB

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies. The company's Phase II clinical trial products comprise Opicinumab for MS; BAN2401 for Alzheimer's disease; BIIB092 for PSP; Natalizumab for Acute Ischemic Stroke and Epilepsy; and BG00011 for idiopathic pulmonary fibrosis. Its Phase I/IIa clinical trial products consist of BIIB080 for patients with mild AD. The company's Phase I clinical trial products comprise Aducanumab for Alzheimer's disease; BIIB076, an anti-tau monoclonal antibody; and BIIB054 for Parkinson's disease. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

BIIB price history

Date Close Change Change(%) Open High Low
Jan 30, 2023 284.58 -1.31 -0.46% 285.89 289.82 283.69
Jan 27, 2023 288.93 -1.85 -0.64% 290.78 295.05 288.93
Jan 26, 2023 290.79 -0.74 -0.25% 291.53 292.73 288.93
Jan 25, 2023 291.22 2.66 0.92% 288.56 292.48 287.58
Jan 24, 2023 290.72 0.16 0.06% 290.56 293.04 288.78
Jan 23, 2023 290.79 7.28 2.57% 283.51 292.08 283.20
Jan 20, 2023 285.10 3.50 1.24% 281.60 286.16 279.81
Jan 19, 2023 279.59 0.46 0.16% 279.13 283.67 279.13
Jan 18, 2023 282.32 -6.27 -2.17% 288.59 291.56 282.11
Jan 17, 2023 288.16 1.10 0.38% 287.06 289.90 284.63
Jan 13, 2023 286.78 0.44 0.15% 286.34 289.16 283.97
Jan 12, 2023 286.78 4.57 1.62% 282.21 288.01 278.88
Jan 11, 2023 284.00 3.16 1.13% 280.84 285.01 280.84
Jan 10, 2023 280.19 6.05 2.21% 274.14 282.84 274.14
Jan 9, 2023 274.58 -5.43 -1.94% 280.01 281.63 268.19
Jan 6, 2023 278.57 5.00 1.83% 273.57 291.83 271.33
Jan 5, 2023 270.80 1.67 0.62% 269.13 272.52 263.85
Jan 4, 2023 270.16 -0.52 -0.19% 270.68 275.12 269.17
Jan 3, 2023 272.32 -1.85 -0.67% 274.17 277.82 270.20
Dec 30, 2022 275.53 2.52 0.92% 273.01 277.00 270.24